LMR Partners LLP

Position in DXCM — Dexcom Inc

CIK 1578621 LONDON, X0

Position in DXCM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$19,410,600

+$7,486,593 QoQ

Shares Held

309,086

+101.6% QoQ

Ownership

0.080%

of shares outstanding

% of Portfolio

0.30%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

LMR Partners LLP holds $196,019,029 across 9 Medical Devices names. DXCM ranks #3 (9.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PEN	Penumbra Inc	295,708	$97,101,635
2	SNN	Smith & Nephew PLC	1,767,872	$56,182,972
3	DXCM	Dexcom Inc This page	309,086	$19,410,600
4	BSX	Boston Scientific Corp	232,801	$14,608,262
5	MASI	Masimo Corp	16,300	$2,899,281
6	EW	Edwards Lifesciences Corp	31,672	$2,536,293
7	MDT	Medtronic plc	19,373	$1,678,670
8	SYK	Stryker Corp	4,707	$1,546,673

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$19,410,600	309,086	+101.6%	Shares	Sole	2026-05-15
2024-12-31	$11,924,007	153,324	+180.6%	Shares	Sole	2025-02-14
2024-03-31	$7,578,568	54,640	+598.0%	Shares	Sole	2024-05-15
2023-12-31	$971,376	7,828	-47.2%	Shares	Sole	2024-02-14
2023-09-30	$1,383,452	14,828	-80.3%	Shares	Sole	2023-11-14
2023-03-31	$8,727,906	75,124	-23.5%	Shares	Sole	2023-05-15
2022-12-31	$11,118,242	98,183	+31.8%	Shares	Sole	2023-02-14
2022-09-30	$6,000,230	74,500	-7.6%	Shares	Sole	2022-11-14
2022-06-30	$6,009,577	80,633	+317.1%	Shares	Sole	2022-08-15
2022-03-31	$2,472,307	19,330	+66.0%	Shares	Sole	2022-05-16
2021-12-31	$1,563,329	11,646	+2296.3%	Shares	Sole	2022-02-14
2021-09-30	$66,443	486	-85.8%	Shares	Sole	2021-11-15
2021-06-30	$364,764	3,417	-65.2%	Shares	Sole	2021-08-16
2020-09-30	$1,012,539	9,825	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.